1047P Pembrolizumab (Pembro) monotherapy for locally advanced or metastatic non–small-cell lung cancer (NSCLC): 10-year outcomes from clinical trials
E.B. Garon, R. Hui, N.B. Leighl, Amita Patnaik et autres
us, hk, ca, cn, ru, ch, es, de (code pays fourni par la source)